Navigation Links
Allon Therapeutics to Present Live, Online at RetailInvestorConferences.com on March 3rd
Date:2/28/2011

with retail investors using a graphically-enhanced online platform.

Designed to replicate the look and feel of location-based investor conferences, Retail Investor Conferences unites PR Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail investor audience network and MUNCmedia's sophisticated retail investor targeting.

Forward-Looking Statements:Statements contained herein, other than those which are strictly statements of historical fact may include forward-looking information. Such statements will typically contain words such as "believes", "may", "plans", "will", "estimate", "continue", "anticipates", "intends", "expects", and similar expressions. While forward-looking statements represent management's outlook based on assumptions that management believes are reasonable, forward-looking statements by their nature are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, events or developments to be materially different from any future results, events or developments expressed or implied by them. Such factors include, among others, the inherent uncertainty involved in scientific research and drug development, Allon's early stage of development, lack of product revenues, its additional capital requirements, the risks associated with successful completion of clinical trials and the long lead-times and high costs associated with obtaining regulatory approval to market any product which Allon may eventually develop. Other risk factors include the limited protections afforded by intellectual property rights, rapid technology and product obsolescence in a highly competitive environment and Allon's dependence on collaborative partners and contract research organizations. These factors can be reviewed in Allon's public filings at www.SEDAR.com and should be considered carefully. Readers are cautioned
'/>"/>

SOURCE Allon Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dr. Joan Fallon, Curemark CEO, Addresses Keystone Symposia Meeting On Autism
2. Nile Therapeutics Announces Plans to Pursue a Post-Acute Indication in Heart Failure
3. Nile Therapeutics to Collaborate with Medtronic on Clinical Development of Cenderitide for Heart Failure and Renal Disease
4. Deston Therapeutics Stands By Safety and Efficacy of Auralgan After FDA Action
5. Silence Therapeutics Issued New U.S. Patent Covering Fundamental RNA Interference Technology Currently in Several Clinical Trials
6. Cornerstone Therapeutics to Host Fourth Quarter and Full Year 2010 Conference Call
7. Echo Therapeutics Reports Symphony™ tCGM System Ahead of Schedule
8. Orexigen® Therapeutics, Inc. Announces Upcoming Departure of Chief Financial Officer
9. Prime Therapeutics Vice President of Specialty Pharmacy Solutions Speaks at 16th Annual PBMI Drug Benefit Conference
10. Echo Therapeutics Announces Appointments to Board of Directors
11. Tarsa Therapeutics Completes Phase III Trial of its Oral Calcitonin for Treatment of Postmenopausal Osteoporosis and Initiates Phase II Trial in Osteoporosis Prevention
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)...  MedVantx, Inc., the company that has pioneered a ... the Company has completed a major expansion of its ... and the upgrade of its systems to offer a ... specialty home delivery pharmacy in Sioux Falls, ... physicians, health systems and payors novel distribution services, as ...
(Date:5/23/2013)... , May 23, 2013   BioLife Solutions , ... proprietary clinical grade hypothermic storage and ... contract aseptic media manufacturer , today announced its ... Regenerative Medicine Congress 2013 this week in ... ) Dr. Aby J. Mathew, BioLife,s Senior ...
(Date:5/23/2013)... 2013 Ranbaxy Laboratories Limited ... Daiichi Sankyo Co., Ltd. (im Weiteren ... die Maßnahmen bekannt, die Ranbaxy in ... sich der Angelegenheiten der vorhergehenden Unternehmensführung ... Daiichi Sankyo unterstützt Ranbaxy ...
Breaking Medicine Technology:MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 2BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress 3Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an 2
... HILL, N.C., Dec. 5, 2011   New product launches ... It is critical for organizations to balance the dueling goals ... challenge that executives face is determining how much to invest, ... of the budget for primary care launch is ...
... OrbusNeich today announced that data published in the November ... is safe when accompanied by only 10 days of dual ... 49 patients treated with Genous, no patient had died or ... myocardial infarction or angiographic evidence of stent thrombosis (ST) ascribable ...
Cached Medicine Technology:Launch Spend Insights: Companies Now Invest More in Launch Year Than in Previous 3 Ramp-Up Years Combined 2Data Published in EuroIntervention Indicate that OrbusNeich's Genous™ Stent Is Safe with Very Short-Term Dual Antiplatelet Therapy 2Data Published in EuroIntervention Indicate that OrbusNeich's Genous™ Stent Is Safe with Very Short-Term Dual Antiplatelet Therapy 3
(Date:5/23/2013)... PA (PRWEB) May 23, 2013 Pittsburgh-based ... allowing seniors to remain independent in their own homes ... Security Alert’s Director of Life Safety, recently commented on ... providers. He stated that although there are numerous ... Automated Security Alert is rare in that they are ...
(Date:5/23/2013)... Sunnyvale, CA (PRWEB) May 23, 2013 Footwear ... Dansko Vista Collection of sandals containing cork footbeds. ... Dansko has had consistently good sales for many years, and ... this spring and summer. , Dansko Shoes ... and the Vista Collection is no exception. Containing leather and ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Kitchen ... hands-on cooking classes, the most advanced culinary technique series ... from class with the knowledge of how to purchase, ... and the health benefits of organic, local ingredients. The ... which are six hours each. The next series begins ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 When Teachers ... product donations to raise funds for the Moore, OK ... dollars worth of items that could be sold for ... However, the staff at Teachers Notebook were overwhelmed by ... pledged $1000.00 worth of materials within the first 12 ...
(Date:5/23/2013)... 911 Signal USA is attending the 2013 Police Fleet ... and run through May 24, 2013. , In addition to ... emergency vehicle lights and sirens, 911 Signal USA will ... expo. , The Charger has been equipped with the best ... seen by visiting 911 Signal USA during the expo at ...
Breaking Medicine News(10 mins):Health News:Automated Security Alert's New Medical Alarm Works Even In Power Outages 2Health News:Footwear etc. Announces the New Collection of Dansko Cork Sandals 2Health News:Kitchen on Fire Launches Intermediate Cooking Series, Advancing the Culinary Skills of Experienced Home Chefs 2Health News:Kitchen on Fire Launches Intermediate Cooking Series, Advancing the Culinary Skills of Experienced Home Chefs 3Health News:Teachers Rally to Raise Funds for Moore Tornado Victims 2Health News:911 Signal USA Attends the 2013 Southwest Police Fleet Expo 2
... first Southern-style canned product ... American Heart Association, COLUMBUS, Ohio, Jan. 9 ... low fat and meatless, were the first,product line of ... savory,taste. Now, heart-healthy Sensibly Seasoned products also bear the ...
... can do quite a number on your teeth. Did ... 11 teaspoons of sugar per serving and,that most soft ... these acids can cause erosion, the loss of hard ... Terry, a Pennsylvania Dental Association (PDA),member and endodontist from ...
... WSB-TV Partner to Collect Bags at 25 Georgia Locations, ... private oncology/ hematology practice in the Southeast -- will team,up ... drive. The,event will be held at 25 GCS offices across ... p.m., "Totes 2 Tots" delivers new or nearly new ...
... lead to better prognosis, treatments, researchers say , , WEDNESDAY, ... on a handful of tiny ribonucleic acid (RNA) molecules ... travels to the lung and bone. , These "microRNAs" ... When they are missing, that allows the disease to ...
... combat mortality , , WEDNESDAY, Jan. 9 (HealthDay News) -- ... question the conventional wisdom of treating with corticosteroids, intensive ... called pentastarch. , The first study compared the ... septic shock and found no improvement in survival rates. ...
... of developmental disorder, researchers say , , WEDNESDAY, Jan. 9 (HealthDay ... risk for developing autism, a new study suggests. , The ... of the causes of a disorder that is turning out ... in its symptoms. Not only is autism complicated, its incidence ...
Cached Medicine News:Health News:Glory Foods Receives Heart Healthy Certification 2Health News:Keep a Watchful Eye on Sugary Beverage Consumption 2Health News:Georgia Cancer Specialists to Sponsor Sixth Annual 'Totes 2 Tots' Suitcase Drive for Foster Children 2Health News:Georgia Cancer Specialists to Sponsor Sixth Annual 'Totes 2 Tots' Suitcase Drive for Foster Children 3Health News:Tiny RNA Molecules Control Breast Cancer's Spread 2Health News:Tiny RNA Molecules Control Breast Cancer's Spread 3Health News:Tiny RNA Molecules Control Breast Cancer's Spread 4Health News:Standard Septic Shock Treatments Ineffective 2Health News:Standard Septic Shock Treatments Ineffective 3Health News:Standard Septic Shock Treatments Ineffective 4Health News:Chromosome Abnormalities Raise Risk for Autism 2Health News:Chromosome Abnormalities Raise Risk for Autism 3Health News:Chromosome Abnormalities Raise Risk for Autism 4
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: